BioSmart Co.Ltd (038460) — Cash Flow Reinvestment Rate
BioSmart Co.Ltd (038460) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩4.12 Billion (capex ₩1.22 Billion plus investments ₩2.90 Billion) from operating cash flow of ₩7.59 Billion. Check BioSmart Co.Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioSmart Co.Ltd Cash Flow Reinvestment Rate (2010–2024)
Historical reinvestment intensity for BioSmart Co.Ltd across 9 annual periods. Explore BioSmart Co.Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for BioSmart Co.Ltd (2010–2024)
Year-by-year capital reinvestment analysis for BioSmart Co.Ltd. For live market cap and broader valuation context, see 038460 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.60x | ₩17.49 Billion | ₩3.80 Billion | ₩8.66 Billion | ▼ -61.0% |
| 2023 | 11.80x | ₩13.75 Billion | ₩1.17 Billion | ₩4.92 Billion | ▲ +469.2% |
| 2022 | 2.07x | ₩11.58 Billion | ₩5.59 Billion | ₩5.87 Billion | ▼ -60.9% |
| 2021 | 5.30x | ₩6.37 Billion | ₩1.20 Billion | ₩5.22 Billion | ▲ +599.2% |
| 2018 | 0.76x | ₩4.41 Billion | ₩5.81 Billion | ₩3.34 Billion | ▼ -68.1% |
| 2014 | 2.37x | ₩3.10 Billion | ₩1.31 Billion | ₩927.27 Million | ▲ +1120.7% |
| 2013 | 0.19x | ₩748.17 Million | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩895.45 Million | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩589.05 Million | ₩4.76 Billion | ₩589.05 Million | — |